Correction To: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?

Annals of Surgical Oncology - United States
doi 10.1245/s10434-020-08273-4
Full Text
Abstract

Available in full text

Categories
OncologySurgery
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Axillary and Internal Mammary Sentinel Lymph Node Biopsy in Breast Cancer After Neoadjuvant Chemotherapy

Oncotarget
Oncology
2016English

A New Model Incorporating Axillary Ultrasound After Neoadjuvant Chemotherapy to Predict Non-Sentinel Lymph Node Metastasis in Invasive Breast Cancer

Cancer Management and Research
Oncology
2020English

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

JAMA - Journal of the American Medical Association
Medicine
2011English

200 Sentinel Lymph Node Biopsies Without Axillary Lymph Node Dissection – No Axillary Recurrences After a 3-Year Follow-Up

British Journal of Cancer
Cancer ResearchOncology
2004English

Correction To: Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

Current Treatment Options in Oncology
OncologyPharmacology
2019English

Completion of Axillary Dissection for a Positive Sentinel Node: Necessary or Not?

Current Oncology Reports
Oncology
2008English

Sentinel Node Biopsy Versus Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2005English

Sentinel-Node Biopsy to Avoid Axillary Dissection in Breast Cancer With Clinically Negative Lymph-Nodes

The Lancet
Medicine
1997English

Partial Axillary Lymph Node Dissection Inferior to the Intercostobrachial Nerves Complements Sentinel Node Biopsy in Patients With Clinically Node-Negative Breast Cancer

BMC Surgery
MedicineSurgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy